Sign in for the best experience.
Without appropriate management, patients with bronchiectasis can experience reduced quality of life and declining lung function. This guideline provides 13 evidence-based recommendations addressing duration and route of antibiotic therapy, long-term suppressive antibiotic and anti-inflammatory therapies, airway clearance strategies, and more.
ACCESS THE FULL GUIDELINE
For adults with frequent exacerbations of bronchiectasis, we suggest long-term inhaled antibiotic therapy.
For adults with frequent exacerbations of bronchiectasis, we suggest long-term macrolide therapy.
For adults with frequent exacerbations of bronchiectasis, we suggest long-term brensocatib therapy.
Advertisement
Our guidelines are aimed at helping you respond to today’s clinical challenges and improve patient health outcomes. Our panel of experts has developed multimedia content to facilitate adoption of this guideline into your day-to-day practice.
CHEST Releases Guideline on Managing Adult Bronchiectasis In a release issued to the media, lead author Rachel Thomson, MBBS, FCCP, speaks to the importance of this guideline in practice.
CHEST offers podcasts, networking opportunities, articles, and more on topics relevant to antithrombotic therapy and thrombosis.
Be prepared for your board exams and advance your knowledge in pulmonary medicine with CHEST Board Review On Demand.
This Network serves as the main resource and forum for issues related to pulmonary infections, as well as disaster response and global health.
Test your clinical knowledge and enhance your studies as you prepare for your board exams or practice for the Longitudinal Knowledge Assessment.